Unlock instant, AI-driven research and patent intelligence for your innovation.

Application of miR-7 in preparation/screening of prostate cancer diagnosis and treatment products

A prostate cancer and mir-7 technology, applied in the field of biomedicine, can solve the problems of prostate cancer diagnosis, prognosis and poor treatment effect, and achieve the effect of inhibiting proliferation and promoting cell apoptosis

Pending Publication Date: 2022-05-27
SOUTHEAST UNIV
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] Aiming at the problem of poor diagnosis, prognosis and therapeutic effect of prostate cancer, the present invention provides the application of miR-7 in the preparation of products for diagnosis and treatment of prostate cancer

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of miR-7 in preparation/screening of prostate cancer diagnosis and treatment products
  • Application of miR-7 in preparation/screening of prostate cancer diagnosis and treatment products
  • Application of miR-7 in preparation/screening of prostate cancer diagnosis and treatment products

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0028] 1. Expression of miR-7 in prostate cancer cells and cancerous tissues

[0029] 1.1. RNA extraction: Tiangen RNA extraction kit is used

[0030] 1) Three kinds of cells PC3, DU145, LNCaP and prostate epithelial cell PBS for prostate cancer are washed twice, and an appropriate amount of pancreatic enzyme is added for digestion;

[0031] 2) Digest for 1 min, add medium to stop digestion at 1000 rpm, centrifuge for 5 min;

[0032] 3) Resuspend cells with a full amount of 150-200 μL cell lysate per centrifuge tube;

[0033] 4) Incubate on ice for 15 min with vortex shaker mixed evenly;

[0034] 5) The solution was added to the filter column CS, centrifuged at 12000 rpm for 2 min, and the filtrate was collected;

[0035] 6) Add filtrate and other volumes of 70% ethanol, mix well and add to the adsorption column CR2, centrifuge at 12000 rpm for 1min, discard the waste liquid, and put the adsorption column back into the collection tube;

[0036]7) Add 350 μL of deproteinization sol...

Embodiment 2

[0092] miR-7 inhibits the glucose metabolism of prostate cancer cells and primary cells, as well as proliferation and cloning

[0093] 1. Detection of cellular glycolytic metabolism level

[0094] 1) Cells in the logarithmic growth phase are selected for experiments, miR-7 (overexpressed miR-7), miR-NC (blank control) transfected into LNCaP and prostate cancer primary cells are added to pancreatic digestion solution digestion cells after 36-48 h and counted. Cell density per well is at 5×10 3 Cells / 80 μL are inoculated in a 96-well test plate dedicated to the Seahorse XF96 analyzer at 37°C, 5% CO 2 Culture overnight in the incubator to adapt the cells to adherent growth;

[0095] 2) Replace the cell culture medium into a special glycolysis stress test medium without glucose, set up the ECAR detection procedure step by step, and test on the SeahorseXF96 analyzer. At this time, the ECAR value is the acidification rate produced by the non-glycolytic pathway. Cells produce CO through ...

Embodiment 3

[0131] Construction of miR-7 transgenic mice

[0132]1. Vector construction: According to the miR-7 sequence, select the appropriate carrier and construct the CAG-miR-7-Luc-PA plasmid. Sequence of pCAG-Gene-intron-BGHpa transgenic DNA fragments:

[0133]

[0134] 2. Mouse preparation:

[0135] 1) Preparation of embryonic donor mice: 5.0 IU of pregnant horse serum gonadotropin (PMSG) is injected intraperitoneally into mature female mice, generally PMSG is injected at 13 to 14 pm, and then 5.0 IU of human chorionic gonadotropin (hCG) is injected after about 48 h, and immediately merged with male mice. The next morning, the female mouse's vaginal plug is examined, and the successfully mated female mouse will be used to retrieve the embryo. In order to obtain a better over-row effect, female rats of 3 to 6 weeks of age are generally selected. Male rats reach sexual maturity at about 8 weeks of age and can be used until their reproductive performance declines (6 to 8 months of age).

[...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses application of miR-7 in preparing / screening prostate cancer diagnosis and treatment products, and belongs to the technical field of biological medicine. The method comprises the following steps: screening micro RNA biomarkers related to prostate cancer cells through a gene chip, selecting miRNA with obvious differential expression, detecting the expression difference in prostate cancer chip tissue and normal tissue, detecting the expression level of the miRNA, and judging whether the miRNA is related to prognosis of prostate cancer or not. The invention provides support for clinically judging whether the prostatic cancer is metastatic or not, and provides application of miR-7 in preparing any one of a product for treating tumors, a product for inhibiting tumor cell proliferation and a product for inhibiting tumor growth.

Description

Technical field [0001] The present invention belongs to the field of biomedical technology, specifically relates to the application of miR-7 in the preparation / screening of prostate cancer diagnosis and treatment products. Background [0002] Worldwide, the incidence of prostate cancer has risen to the first place in male malignancy. According to estimates by the American Oncology Association, by 2021, there will be nearly 248,530 newly confirmed cases in the United States, accounting for 26% of confirmed cases in men, with incidence accounting for the first of all cancers in men and the second highest mortality rate, second only to lung cancer. The incidence of prostate cancer in Asian countries is relatively low, but in recent years, the rising trend of prostate cancer in both incidence and mortality is obvious, and the growth is more rapid than that of developed countries in Europe and the United States. In China, with the entry into the aging society, the incidence of prost...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12Q1/6886C12Q1/6851C12N15/85A01K67/027A61K45/00A61P35/00
CPCC12Q1/6886C12Q1/6851C12N15/8509A01K67/0275A61K45/00A61P35/00C12Q2600/178C12Q2600/158C12Q2600/118A01K2207/05A01K2227/105A01K2267/0331C12Q2531/113C12Q2545/101C12Q2563/107
Inventor 陈明王灿许斌尤宗昊刘春辉陈恕求胡强
Owner SOUTHEAST UNIV